90-day CGM implant receives recommendation for FDA approval
Eversense, a continuous glucose monitor from Senseonics that is implanted subcutaneously in the arm for up to three months, has been recommended for approval by an FDA advisory committee. Read more
Malnourished Patients Fall Through the Cracks in America’s Hospitals
A persistent lack of awareness about the dangers of malnutrition among patients is contributing to higher mortality rates and longer hospital stays. Source: Malnourished Patients Fall Read more
DPP-4I Not Tied to Increased Risk of Acute Pancreatitis in Seniors
Among adults with heart disease, risk increased with DPP-4I versus thiazolidinedione not sulfonylureas Source: DPP-4I Not Tied to Increased Risk of Acute Pancreatitis in Read more
SGLT-2 Inhibitors: The Best Bet Among New T2D Drugs?
Sodium-glucose cotransporter 2 (SGLT-2) inhibitors came out on top in a large meta-analysis of clinical trials that compared the newer classes of diabetes drugs head-to-head in terms of Read more